A61K 9/2063
Proteins
Official title: {Proteins, e.g. gelatin}
A61K9/2063 (Proteins) appears on 242 US grants and 366 published applications in this corpus.
Search patents in A61K- Granted patents
- 242
- Published applications
- 366
- Assignees
- 228
- Inventors
- 741
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 0 |
| 2002 | 8 | 6 |
| 2003 | 7 | 10 |
| 2004 | 2 | 15 |
| 2005 | 3 | 6 |
| 2006 | 2 | 6 |
| 2007 | 1 | 9 |
| 2008 | 1 | 10 |
| 2009 | 2 | 10 |
| 2010 | 4 | 15 |
| 2011 | 3 | 15 |
| 2012 | 5 | 11 |
| 2013 | 6 | 18 |
| 2014 | 9 | 9 |
| 2015 | 8 | 15 |
| 2016 | 12 | 17 |
| 2017 | 10 | 22 |
| 2018 | 11 | 19 |
| 2019 | 11 | 15 |
| 2020 | 14 | 27 |
| 2021 | 11 | 19 |
| 2022 | 7 | 19 |
| 2023 | 6 | 28 |
| 2024 | 11 | 23 |
| 2025 | 14 | 10 |
| 2026 | 4 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lactobacillus paracasei ATG-EI strain or composition comprising same for preventing or treating respiratory disease30 Jun 2026US 12,667,598 B2Atogen Co., Ltd
- Pharmaceutical dosage forms and methods of use7 Apr 2026US 12,594,281 B2Emalex Biosciences, Inc.
- Immediate release formulations of d-lysergic acid diethylamide for therapeutic applications20 Jan 2026US 12,527,786 B2Mind Medicine, Inc.
- Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications13 Jan 2026US 12,521,385 B2Mind Medicine, Inc.
- Veterinary pharmaceutical compositions for direct systemic introduction16 Dec 2025US 12,496,295 B2NewMarket Pharmaceuticals LLC
- Cannabinoid formulations17 Sep 2026US 2026/0272953 A1Dsm IP Assets B.V.
- Palatable chewable compositions with improved taste masking20 Aug 2026US 2026/0240782 A1Harmony Foods, Inc.
- Pharmaceutical dosage forms and methods of use16 Jul 2026US 2026/0199366 A1Emalex Biosciences, Inc.
- Palatable chewable compositions with improved taste masking9 Jul 2026US 2026/0191790 A1Harmony Foods, Inc.
- Fast-dissolving dosage forms and uses thereof4 Jun 2026US 2026/0151345 A1Astrocyte Pharmaceuticals, Inc.
Most cited
By later US patents
- Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines288US 5,635,517 ACelgene Corporation · 1997
- Articles for carrying chemicals235US 4,371,516 AJohn Wyeth & Brother Limited · 1983
- Sustained-release pharmaceutical compositions216US 5,023,082 AYissum Research Development Company of the Hebrew University of Jerusalem · 1991
- Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents196US 4,925,677 ATheratech, Inc. · 1990
- Sustained release formulation195US 5,922,356 AKoken Co., Ltd. · 1999